SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001654954-18-010974
Filing Date
2018-10-11
Accepted
2018-10-11 06:41:22
Documents
16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT f-1_a2.htm F-1/A 1358041
2 UNDERWRITING AGREEMENT ex11.htm EX-1.1 319994
3 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ex426.htm EX-4.26 117361
4 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ex427.htm EX-4.27 122627
5 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU ex428.htm EX-4.28 130035
6 OPINION ON LEGALITY ex51.htm EX-5.1 30519
7 OPINION ON LEGALITY ex52.htm EX-5.2 23098
8 CONSENTS OF EXPERTS AND COUNSEL ex231.htm EX-23.1 4503
9 CONSENTS OF EXPERTS AND COUNSEL ex232.htm EX-23.2 7045
10 IMAGE birlogo.jpg GRAPHIC 8913
11 IMAGE deloitte_logo.jpg GRAPHIC 2439
12 IMAGE gowlings1.jpg GRAPHIC 7034
13 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
14 IMAGE mnp_address-1.jpg GRAPHIC 5048
15 IMAGE mnp_address-2.jpg GRAPHIC 6286
16 IMAGE mnp_logo.jpg GRAPHIC 2454
  Complete submission text file 0001654954-18-010974.txt   2169580
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: F-1/A | Act: 33 | File No.: 333-227448 | Film No.: 181117242
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences